Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of 0.13% CBD Acne Cream in Acne Vulgaris Treatment
TCTR20241022006Phase 2Completed
- Sponsor
- Thammasat University Hospital
- Start
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cannabidiol in acne vulgaris, sponsored by Thammasat University Hospital. Started Mar 2023; status: completed.
02
Drugs
cannabidiol
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on TCTR20241022006.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20241022006.